| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_SMARCA5_0000100 | Exon-Exon | chr4:144434670-144464799 | chr4:143513517-143543646 | 2449 nt | 0.4602 |
| hsa_SMARCA5_0000200 | Intron-Intron | chr4:144436451-144436845 | chr4:143515298-143515692 | 395 nt | 0.3291 |
| hsa_SMARCA5_0000300 | Intron-Exon-Intron | chr4:144436674-144451679 | chr4:143515521-143530526 | 410 nt | 0.3707 |
| hsa_SMARCA5_0000400 | Exon-Exon | chr4:144438508-144442748 | chr4:143517355-143521595 | 75 nt | 0.3733 |
| hsa_SMARCA5_0000500 | Exon-Exon | chr4:144438508-144449176 | chr4:143517355-143528023 | 176 nt | 0.4148 |
| hsa_SMARCA5_0000600 | Exon-Exon | chr4:144438508-144451679 | chr4:143517355-143530526 | 276 nt | 0.3804 |
| hsa_SMARCA5_0000900 | Exon-Exon | chr4:144442582-144447613 | chr4:143521429-143526460 | 167 nt | 0.4192 |
| hsa_SMARCA5_0001000 | Exon-Exon | chr4:144442582-144451679 | chr4:143521429-143530526 | 236 nt | 0.4153 |
| hsa_SMARCA5_0000800 | Exon-Exon | chr4:144442582-144456117 | chr4:143521429-143534964 | 1016 nt | 0.3907 |
| hsa_SMARCA5_0000700 | Exon-Exon | chr4:144442582-144471257 | chr4:143521429-143550104 | 2841 nt | 0.3911 |
A study in mice demonstrated that the circSMARCA5 promotes angiogenesis by sponging SRSF1 mRNA to regulate VEGF-A [Mehta et al. DOI:10.1016/j.pneurobio.2020.101746]. A study in human bloodstains demonstrated that the circSMARCA5 exhibited linear degradation over 120 days, with its relative expression negatively correlated with bloodstain age both indoors (r=0.81) and outdoors (r=0.91), and it was incorporated into a mathematical formula for estimating the time since deposition [Wei et al. DOI:10.1016/j.forsciint.2022.111408]. A separate review noted that in human plasma, the circSMARCA5 is lower in patients with more severe coronary atherosclerosis, with an AUC of 0.589, indicating its potential as a diagnostic biomarker for stable coronary artery disease [Tian et al. DOI:10.3390/molecules26041155].